Biomarker imaging 2 years [clinicaltrials_resource:3037ce8bd7861b4fea753ed460739552]

Biomarker imaging 2 years [clinicaltrials_resource:3037ce8bd7861b4fea753ed460739552]

Part 1, Biomarker imaging: 89Zr-GC1008 PET imaging in patients with suspicion of a malignant glioma: Primary endpoint: - Quantification of uptake of 89Zr-GC1008 as determined by PET imaging. The data obtained from the PET-scans will be quantified as standardized uptake value (SUV).
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:3037ce8bd7861b4fea753ed460739552
Safety and Imaging Study of GC1008 in Glioma [clinicaltrials:NCT01472731]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Biomarker imaging 2 years [clinicaltrials_resource:3037ce8bd7861b4fea753ed460739552]

Part 1, Biomarker imaging: 89Zr-GC1008 PET imaging in patients with suspicion of a malignant glioma: Primary endpoint: - Quantification of uptake of 89Zr-GC1008 as determined by PET imaging. The data obtained from the PET-scans will be quantified as standardized uptake value (SUV).
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:3037ce8bd7861b4fea753ed460739552
Bio2RDF identifier
3037ce8bd7861b4fea753ed460739552
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3037ce8bd7861b4fea753ed460739552
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
description
Part 1, Biomarker imaging: 89Z ...... andardized uptake value (SUV).
identifier
clinicaltrials_resource:3037ce8bd7861b4fea753ed460739552
title
Biomarker imaging 2 years
@en
inDataset
type
label
Biomarker imaging 2 years [clinicaltrials_resource:3037ce8bd7861b4fea753ed460739552]
@en